Related references
Note: Only part of the references are listed.GPR55 deficiency is associated with increased adiposity and impaired insulin signaling in peripheral metabolic tissues
Christopher Lipina et al.
FASEB JOURNAL (2019)
Cannabinoid receptor type-1 partially mediates metabolic endotoxemia-induced inflammation and insulin resistance
Zachary I. Grunewald et al.
PHYSIOLOGY & BEHAVIOR (2019)
Intestinal epithelial N-acylphosphatidylethanolamine phospholipase D links dietary fat to metabolic adaptations in obesity and steatosis
Amandine Everard et al.
NATURE COMMUNICATIONS (2019)
High Fat Diet Increases Circulating Endocannabinoids Accompanied by Increased Synthesis Enzymes in Adipose Tissue
Eline N. Kuipers et al.
FRONTIERS IN PHYSIOLOGY (2019)
Probiotics, prebiotics, synbiotics and insulin sensitivity
Y. A. Kim et al.
NUTRITION RESEARCH REVIEWS (2018)
Endocannabinoids in the Islets of Langerhans: the ugly, the bad, and the good facts
Isabel Gonzalez-Mariscal et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2018)
Plasma endocannabinoid levels in lean, overweight, and obese humans: relationships to intestinal permeability markers, inflammation, and incretin secretion
Tanya J. Little et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2018)
The therapeutic potential of targeting the peripheral endocannabinoid/CB1 receptor system
Joseph Tam et al.
EUROPEAN JOURNAL OF INTERNAL MEDICINE (2018)
Lysophosphatidylinositols, from Cell Membrane Constituents to GPR55 Ligands
Mireille Alhouayek et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2018)
Comparing olive oil and C4-dietary oil, a prodrug for the GPR119 agonist, 2-oleoyl glycerol, less energy intake of the latter is needed to stimulate incretin hormone secretion in overweight subjects with type 2 diabetes
Mette Johannsen Mandoe et al.
NUTRITION & DIABETES (2018)
Caloric restriction lowers endocannabinoid tonus and improves cardiac function in type 2 diabetes
Huub J. van Eyk et al.
NUTRITION & DIABETES (2018)
Peripheral CB1 Receptor Neutral Antagonist, AM6545, Ameliorates Hypometabolic Obesity and Improves Adipokine Secretion in Monosodium Glutamate Induced Obese Mice
Haiming Ma et al.
FRONTIERS IN PHARMACOLOGY (2018)
Profiling plasma N-Acylethanolamine levels and their ratios as a biomarker of obesity and dysmetabolism
Flaminia Fanelli et al.
MOLECULAR METABOLISM (2018)
New approaches and challenges to targeting the endocannabinoid system
Vincenzo Di Marzo
NATURE REVIEWS DRUG DISCOVERY (2018)
The relationship between cannabis use and diabetes: Results from the National Epidemiologic Survey on Alcohol and Related Conditions III
Sameer Imtiaz et al.
DRUG AND ALCOHOL REVIEW (2018)
Therapeutic application of GPR119 ligands in metabolic disorders
Jin Won Yang et al.
DIABETES OBESITY & METABOLISM (2018)
The metabolic effects of a commercially available chicken peri-peri (African bird's eye chilli) meal in overweight individuals
Jacolene Kroff et al.
BRITISH JOURNAL OF NUTRITION (2017)
PPARs in obesity-induced T2DM, dyslipidaemia and NAFLD
Barbara Gross et al.
NATURE REVIEWS ENDOCRINOLOGY (2017)
Serum Levels of Endocannabinoids are Independently Associated with Nonalcoholic Fatty Liver Disease
Shira Zelber-Sagi et al.
OBESITY (2017)
The role of CB1 in intestinal permeability and inflammation
Mustafa A. Karwad et al.
FASEB JOURNAL (2017)
Oleoylethanolamine and palmitoylethanolamine modulate intestinal permeability in vitro via TRPV1 and PPARα
Mustafa A. Karwad et al.
FASEB JOURNAL (2017)
PPARγ Modulates Long Chain Fatty Acid Processing in the Intestinal Epithelium
Kalina Duszka et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Adipocyte cannabinoid receptor CB1 regulates energy homeostasis and alternatively activated macrophages
Inigo Ruiz de Azua et al.
JOURNAL OF CLINICAL INVESTIGATION (2017)
*Endocannabinoid system acts as a regulator of immune homeostasis in the gut
Nandini Acharya et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Dietary Capsaicin Improves Glucose Homeostasis and Alters the Gut Microbiota in Obese Diabetic ob/ob Mice
Jun-Xian Song et al.
FRONTIERS IN PHYSIOLOGY (2017)
Decreasing CB1 receptor signaling in Kupffer cells improves insulin sensitivity in obese mice
Tony Jourdan et al.
MOLECULAR METABOLISM (2017)
Plasma 2-arachidonoylglycerol is a biomarker of age and menopause related insulin resistance and dyslipidemia in lean but not in obese men and women
Flaminia Fanelli et al.
MOLECULAR METABOLISM (2017)
The cannabinoid ligand LH-21 reduces anxiety and improves glucose handling in diet-induced obese pre-diabetic mice
Silvana Y. Romero-Zerbo et al.
SCIENTIFIC REPORTS (2017)
Cannabidiol and palmitoylethanolamide are anti-inflammatory in the acutely inflamed human colon
Daniel G. Couch et al.
CLINICAL SCIENCE (2017)
N-acyl Taurines and Acylcarnitines Cause an Imbalance in Insulin Synthesis and Secretion Provoking β Cell Dysfunction in Type 2 Diabetes
Michaela Aichler et al.
CELL METABOLISM (2017)
Effects of twelve weeks of capsaicinoid supplementation on body composition, appetite and self-reported caloric intake in overweight individuals
Stacie L. Urbina et al.
APPETITE (2017)
Gastric Bypass Surgery Recruits a Gut PPAR-α-Striatal D1R Pathway to Reduce Fat Appetite in Obese Rats
Mohammed K. Hankir et al.
CELL METABOLISM (2017)
Role of cannabinoid receptor 1 in human adipose tissue for lipolysis regulation and insulin resistance
Cherno O. Sidibeh et al.
ENDOCRINE (2017)
Role of the endocannabinoid system in diabetes and diabetic complications
G. Gruden et al.
BRITISH JOURNAL OF PHARMACOLOGY (2016)
Deletion of G-protein-coupled receptor 55 promotes obesity by reducing physical activity
A. Meadows et al.
INTERNATIONAL JOURNAL OF OBESITY (2016)
G Protein-Coupled Receptor 119 (GPR119) Agonists for the Treatment of Diabetes: Recent Progress and Prevailing Challenges
Kurt Ritter et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
Early Low-Fat Diet Enriched With Linolenic Acid Reduces Liver Endocannabinoid Tone and Improves Late Glycemic Control After a High-Fat Diet Challenge in Mice
Laurent Demizieux et al.
DIABETES (2016)
Efficacy and Safety of Cannabidiol and Tetrahydrocannabivarin on Glycemic and Lipid Parameters in Patients With Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Pilot Study
Khalid A. Jadoon et al.
DIABETES CARE (2016)
Metabolic effects of orally administered small-molecule agonists of GPR55 and GPR119 in multiple low-dose streptozotocin-induced diabetic and incretin-receptor-knockout mice
Aine M. McKillop et al.
DIABETOLOGIA (2016)
GPR119: a promising target for nonalcoholic fatty liver disease
Jin Won Yang et al.
FASEB JOURNAL (2016)
Human CB1 Receptor Isoforms, present in Hepatocytes and β-cells, are Involved in Regulating Metabolism
Isabel Gonzalez-Mariscal et al.
SCIENTIFIC REPORTS (2016)
Transient receptor potential vanilloid type-1 channel regulates diet-induced obesity, insulin resistance, and leptin resistance
Eunjung Lee et al.
FASEB JOURNAL (2015)
Effect of oleoylethanolamide on diet-induced nonalcoholic fatty liver in rats
Long Li et al.
JOURNAL OF PHARMACOLOGICAL SCIENCES (2015)
Fetal endocannabinoids orchestrate the organization of pancreatic islet microarchitecture
Katarzyna Malenczyk et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Polypharmacology Shakes Hands with Complex Aetiopathology
James S. Brodie et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2015)
Adipose tissue NAPE-PLD controls fat mass development by altering the browning process and gut microbiota
Lucie Geurts et al.
NATURE COMMUNICATIONS (2015)
Changes in Plasma Levels of N-Arachidonoyl Ethanolamine and N-Palmitoylethanolamine following Bariatric Surgery in Morbidly Obese Females with Impaired Glucose Homeostasis
Akhila Mallipedhi et al.
JOURNAL OF DIABETES RESEARCH (2015)
Acute Activation of Cannabinoid Receptors by Anandamide Reduces Gastrointestinal Motility and Improves Postprandial Glycemia in Mice
Stephanie Troy-Fioramonti et al.
DIABETES (2015)
Circulating Endocannabinoids and the Polymorphism 385C>A in Fatty Acid Amide Hydrolase (FAAH) Gene May Identify the Obesity Phenotype Related to Cardiometabolic Risk: A Study Conducted in a Brazilian Population of Complex Interethnic Admixture
Cyro Jose de Moraes Martins et al.
PLOS ONE (2015)
Palmitoylethanolamide normalizes intestinal motility in a model of post-inflammatory accelerated transit: involvement of CB1 receptors and TRPV1 channels
Raffaele Capasso et al.
BRITISH JOURNAL OF PHARMACOLOGY (2014)
Palmitoylethanolamide improves colon inflammation through an enteric glia/toll like receptor 4-dependent PPAR-α activation
Giuseppe Esposito et al.
GUT (2014)
Hepatic Cannabinoid-1 Receptors Mediate Diet-Induced Insulin Resistance by Increasing De Novo Synthesis of Long-Chain Ceramides
Resat Cinar et al.
HEPATOLOGY (2014)
Circulating endocannabinoids in insulin sensitive vs. Insulin resistant obese postmenopausal women. A MONET group study
Joseph Abdulnour et al.
OBESITY (2014)
The Impact of Marijuana Use on Glucose, Insulin, and Insulin Resistance among US Adults
Elizabeth A. Penner et al.
AMERICAN JOURNAL OF MEDICINE (2013)
Evaluation of the insulin releasing and antihyperglycaemic activities of GPR55 lipid agonists using clonal beta-cells, isolated pancreatic islets and mice
A. M. McKillop et al.
BRITISH JOURNAL OF PHARMACOLOGY (2013)
The Endocannabinoid System in Energy Homeostasis and the Etiopathology of Metabolic Disorders
Cristoforo Silvestri et al.
CELL METABOLISM (2013)
Gut metagenome in European women with normal, impaired and diabetic glucose control
Fredrik H. Karlsson et al.
NATURE (2013)
Activation of the Nlrp3 inflammasome in infiltrating macrophages by endocannabinoids mediates beta cell loss in type 2 diabetes
Tony Jourdan et al.
NATURE MEDICINE (2013)
Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity
Amandine Everard et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
The cannabinoid Δ9-tetrahydrocannabivarin (THCV) ameliorates insulin sensitivity in two mouse models of obesity
E. T. Wargent et al.
NUTRITION & DIABETES (2013)
Cannabinoids mediate opposing effects on inflammation-induced intestinal permeability
A. Alhamoruni et al.
BRITISH JOURNAL OF PHARMACOLOGY (2012)
Peripheral Cannabinoid-1 Receptor Inverse Agonism Reduces Obesity by Reversing Leptin Resistance
Joseph Tam et al.
CELL METABOLISM (2012)
Expression and Function of Monoacylglycerol Lipase in Mouse beta-cells and Human Islets of Langerhans
Chen Li et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2012)
The L-α-Lysophosphatidylinositol/GPR55 System and Its Potential Role in Human Obesity
Jose Maria Moreno-Navarrete et al.
DIABETES (2012)
Transient Receptor Potential Vanilloid 1 Activation Enhances Gut Glucagon-Like Peptide-1 Secretion and Improves Glucose Homeostasis
Peijian Wang et al.
DIABETES (2012)
Second generation CB1 receptor blockers and other inhibitors of peripheral endocannabinoid overactivity and the rationale of their use against metabolic disorders
Cristoforo Silvestri et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2012)
The therapeutic potential of GPR119 agonists for type 2 diabetes
Takahide Ohishi et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2012)
Hepatic Cannabinoid Receptor-1 Mediates Diet-Induced Insulin Resistance via Inhibition of Insulin Signaling and Clearance in Mice
Jie Liu et al.
GASTROENTEROLOGY (2012)
The Cannabinoid Receptor CB1 Modulates the Signaling Properties of the Lysophosphatidylinositol Receptor GPR55
Julia Kargl et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
A metagenome-wide association study of gut microbiota in type 2 diabetes
Junjie Qin et al.
NATURE (2012)
Type 2 Diabetes Associated Changes in the Plasma Non-Esterified Fatty Acids, Oxylipins and Endocannabinoids
Dmitry Grapov et al.
PLOS ONE (2012)
A Cute Desensitization of TRPV1
Filip Touska et al.
CURRENT PHARMACEUTICAL BIOTECHNOLOGY (2011)
Cannabinoids Inhibit Insulin Receptor Signaling in Pancreatic β-Cells
Wook Kim et al.
DIABETES (2011)
Cannabinoid Receptor Type 1 (CB1R) Signaling Regulates Hepatic Gluconeogenesis via Induction of Endoplasmic Reticulum-bound Transcription Factor cAMP-responsive Element-binding Protein H (CREBH) in Primary Hepatocytes
Dipanjan Chanda et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
2-Oleoyl Glycerol Is a GPR119 Agonist and Signals GLP-1 Release in Humans
Katrine B. Hansen et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
A role for the putative cannabinoid receptor GPR55 in the islets of Langerhans
Silvana Y. Romero-Zerbo et al.
JOURNAL OF ENDOCRINOLOGY (2011)
Dietary Capsaicin Attenuates Metabolic Dysregulation in Genetically Obese Diabetic Mice
Ji-Hye Kang et al.
JOURNAL OF MEDICINAL FOOD (2011)
A novel CB receptor GPR55 and its ligands are involved in regulation of gut movement in rodents
X. -H. Lin et al.
NEUROGASTROENTEROLOGY AND MOTILITY (2011)
Effect of dietary krill oil supplementation on the endocannabinoidome of metabolically relevant tissues from high-fat-fed mice
Fabiana Piscitelli et al.
NUTRITION & METABOLISM (2011)
The neutral cannabinoid CB1 receptor antagonist AM4113 regulates body weight through changes in energy intake in the rat
Nina L. Cluny et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2011)
Altered gut microbiota and endocannabinoid system tone in obese and diabetic leptin-resistant mice: impact on apelin regulation in adipose tissue
Lucie Geurts et al.
FRONTIERS IN MICROBIOLOGY (2011)
Rimonabant: FromRIO to Ban
Amir H. Sam et al.
JOURNAL OF OBESITY (2011)
GPR55: Current Knowledge and Future Perspectives of a Purported Type-3 Cannabinoid Receptor
A. Moriconi et al.
CURRENT MEDICINAL CHEMISTRY (2010)
Cannabinoid Receptor Stimulation Impairs Mitochondrial Biogenesis in Mouse White Adipose Tissue, Muscle, and Liver The Role of eNOS, p38 MAPK, and AMPK Pathways
Laura Tedesco et al.
DIABETES (2010)
CB1 Antagonism Exerts Specific Molecular Effects on Visceral and Subcutaneous Fat and Reverses Liver Steatosis in Diet-Induced Obese Mice
Tony Jourdan et al.
DIABETES (2010)
Effects of in vitro antagonism of endocannabinoid-1 receptors on the glucose transport system in normal and insulin-resistant rat skeletal muscle
K. A. Lindborg et al.
DIABETES OBESITY & METABOLISM (2010)
Deficiency of CB2 cannabinoid receptor in mice improves insulin sensitivity but increases food intake and obesity with age
J. Agudo et al.
DIABETOLOGIA (2010)
Peripheral CB1 cannabinoid receptor blockade improves cardiometabolic risk in mouse models of obesity
Joseph Tam et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
Naphthalen-1-yl-(4-pentyloxynaphthalen-1-yl) methanone (SAB378), a Peripherally Restricted Cannabinoid CB1/CB2 Receptor Agonist, Inhibits Gastrointestinal Motility but Has No Effect on Experimental Colitis in Mice
Nina L. Cluny et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2010)
The endocannabinoid system links gut microbiota to adipogenesis
Giulio G. Muccioli et al.
MOLECULAR SYSTEMS BIOLOGY (2010)
Dietary Capsaicin Reduces Obesity-induced Insulin Resistance and Hepatic Steatosis in Obese Mice Fed a High-fat Diet
Ji-Hye Kang et al.
OBESITY (2010)
GPR119 Is Essential for Oleoylethanolamide-Induced Glucagon-Like Peptide-1 Secretion From the Intestinal Enteroendocrine L-Cell
Lina M. Lauffer et al.
DIABETES (2009)
Changes in plasma endocannabinoid levels in viscerally obese men following a 1 year lifestyle modification programme and waist circumference reduction: associations with changes in metabolic risk factors
V. Di Marzo et al.
DIABETOLOGIA (2009)
Cannabinoid type 1 receptors in human skeletal muscle cells participate in the negative crosstalk between fat and muscle
K. Eckardt et al.
DIABETOLOGIA (2009)
Beneficial effect of a chronic treatment with rimonabant on pancreatic function and β-cell morphology in Zucker Fatty rats
Valerie F. Duvivier et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2009)
Cannabinoid CB2 Receptor Potentiates Obesity-Associated Inflammation, Insulin Resistance and Hepatic Steatosis
Vanessa Deveaux et al.
PLOS ONE (2009)
Targeted enhancement of oleoylethanolamide production in proximal small intestine induces across-meal satiety in rats
Jin Fu et al.
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2008)
The role of endocannabinoids in the regulation of gastric emptying: alterations in mice fed a high-fat diet
V. Di Marzo et al.
BRITISH JOURNAL OF PHARMACOLOGY (2008)
The Lipid Messenger OEA Links Dietary Fat Intake to Satiety
Gary J. Schwartz et al.
CELL METABOLISM (2008)
Hepatic CB1 receptor is required for development of diet-induced steatosis, dyslipidemia, and insulin and leptin resistance in mice
Douglas Osei-Hyiaman et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
Dysregulation of peripheral endocannabinoid levels in hyperglycernia and obesity: Effect of high fat diets
Isabel Matias et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2008)
Role of cannabinoid CB2 receptors in glucose homeostasis in rats
Francisco Javier Bermudez-Silva et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2007)
Activation of transient receptor potential vanilloid type-1 channel prevents adipogenesis and obesity
Li Li Zhang et al.
CIRCULATION RESEARCH (2007)
Circulating endocannabinoid levels, abdominal adiposity and related cardiometabolic risk factors in obese men
M. Cote et al.
INTERNATIONAL JOURNAL OF OBESITY (2007)
Efficacy and tolerability of rimonabant in overweight or obese patients with type 2 diabetes: a randomised controlled study
Andre J. Scheen et al.
LANCET (2006)
Dysregulation of the peripheral and adipose tissue endocannabinoid system in human abdominal obesity
Matthias Blueher et al.
DIABETES (2006)
Regulation, function, and dysregulation of endocannabinoids in models of adipose and β-pancreatic cells and in obesity and hyperglycemia
Isabel Matias et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
Deorphanization of a G protein-coupled receptor for oleoylethanolamide and its use in the discovery of small-molecule hypophagic agents
HA Overton et al.
CELL METABOLISM (2006)
Effect of rimonabant, a cannabinoid-1 receptor blocker, on weight and cardiometabolic risk factors in overweight or obese patients - RIO-North America: A randomized controlled trial
F Pi-Sunyer et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
The emerging role of the endocannabinoid system in endocrine regulation and energy balance
U Pagotto et al.
ENDOCRINE REVIEWS (2006)
Effects of rimonabant on metabolic risk factors in overweight patients with dyslipidemia
JP Despres et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Activation of the peripheral endocannabinoid system in human obesity
S Engeli et al.
DIABETES (2005)
Endocannabinoid activation at hepatic CB1 receptors stimulates fatty acid synthesis and contributes to diet-induced obesity
D Osei-Hyiaman et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients:: 1-year experience from the RIO-Europe study
LF Van Gaal et al.
LANCET (2005)
Molecular characterization of a phospholipase D generating anandamide and its congeners
Y Okamoto et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Cloning of the first sn1-DAG lipases points to the spatial and temporal regulation of endocannabinoid signaling in the brain
T Bisogno et al.
JOURNAL OF CELL BIOLOGY (2003)
Brain monoglyceride lipase participating in endocannabinoid inactivation
TP Dinh et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Cannabinoids and the gastrointestinal tract
RG Pertwee
GUT (2001)
Share Paper
